# A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)

> **NCT00410514** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 200 (actual)

## Conditions studied

- Lower Urinary Tract Symptoms
- Bladder Outlet Obstruction

## Interventions

- **DRUG:** Mirabegron
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00410514
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2014-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00410514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00410514, "A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00410514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*